Cargando…
Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
Epithelial ovarian cancer (EOC) is the 5th leading cause of cancer-associated death in females worldwide. Although 80% of cases respond well to initial treatment, >70% develop recurrent disease and become chemoresistant within the first two years. Therefore, there is a great need for predictive b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719262/ https://www.ncbi.nlm.nih.gov/pubmed/34987799 http://dx.doi.org/10.3892/mco.2021.2462 |